Ajax Therapeutics
Drug DiscoveryWebsite
Developer of targeted therapy drugs designed for the treatment of hematologic cancers. The company leverages advances in molecular genetics and biology to develop new classes of therapies that are hig...
Valuation
$192.5M
Market implied
Share Price
N/A
Total Raised
$143M
Last Round
Later Stage VC (Series C)
May 2024
Latest Funding Round
Later Stage VC (Series C)
May 13, 2024
$95M
raised
Investors
+11 other investors